 
      Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations forward, aiming to accelerate the development of telemedicine and remote cardiology in particular. After more than 9 years since the initiation of the idea, dozens of various prototypes and continuous development, HeartIn is ready to present its product â the future of remote cardiac assessment, which is available already today. According to WHO, more than 10 000 000 people die every year due to cardiovascular diseases. What is even more shocking, 80% of these deaths could have been prevented. We live in a busy world, and itâs often hard to convince yourself to visit a hospital without actual need. Our goal is to provide people with an easy-to-use tool for medical grade accuracy heart monitoring, which can be performed anywhere. Source
No articles found.
 
                  CytoDyn is a publicly traded late stage biotechnology company developing innovativ...
CytoDyn is a publicly traded late stage biotech...
 
                  Diffusion Pharmaceuticals is a clinical stage company focused on improving the eff...
Diffusion Pharmaceuticals is a clinical stage c...
 
                  The recognized global leader in neuromodulation devices to treat blindness, the co...
The recognized global leader in neuromodulation...
 
                  BioSculpture Technology, Inc. (âBSTâ) is a commercial-stage medical device man...
BioSculpture Technology, Inc. (âBSTâ) is a ...
 
                  At Affimed, we are committed to improving outcomes for patients with cancer. Our s...
At Affimed, we are committed to improving outco...
 
                  Robovet Corporation has developed a new MR imaging technology that can also help t...
Robovet Corporation has developed a new MR imag...
 
                  Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (â...
Lantheus Holdings, Inc. is the parent company o...
Join the National Investor Network and get the latest information with your interests in mind.